Santhera Pharmaceuticals Appoints Catherine Isted as CFO, Andrew Smith to Step Down
Position
Chief Financial Officer
Company
Santhera Pharmaceuticals
PrattelnBiotechnologyHealth CareTherapeuticsPharmaceuticalBiopharmaPharmaceutical ManufacturingpharmaceuticalsDescription
Catherine Isted, an experienced healthcare CFO with over 25 years in life sciences, has been appointed as CFO effective February 24, 2025. Current CFO Andrew Smith will step down after five years with Santhera and will support an orderly transition. The appointment of Catherine Isted brings proven financial leadership to support the next growth phase of Santhera Pharmaceuticals.
Quick answer
Santhera Pharmaceuticals Appoints Catherine Isted as CFO, Andrew Smith to Step Down (February 10, 2025). Santhera Pharmaceuticals is based in Pratteln, Basel-Landschaft, Switzerland.
- What did Santhera Pharmaceuticals announce on February 10, 2025?
- Catherine Isted, an experienced healthcare CFO with over 25 years in life sciences, has been appointed as CFO effective February 24, 2025. Current CFO Andrew Smith will step down after five years with Santhera and will support an orderly transition.
- What does Santhera Pharmaceuticals do?
- Santhera Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of innovative medicines for the treatment of rare neuromuscular and pulmonary diseases.
- Where is Santhera Pharmaceuticals based?
- Santhera Pharmaceuticals is based in Pratteln, Basel-Landschaft, Switzerland.
- Which similar companies made leadership changes around the same time?
- Pfizer (February 24, 2025), Daiichi Sankyo (January 31, 2025), Bristol Myers Squibb (February 21, 2025) and Crinetics Pharmaceuticals (February 26, 2025) also announced leadership changes within 45 days of Santhera Pharmaceuticals.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Pfizer Hires Dr. Patrizia Cavazzoni as Chief Medical Officer to Replace Dr. Aida Habtezion (February 24, 2025)
- Daiichi Sankyo Names Hiroyuki Okuzawa as Chief Executive Officer (CEO) succeeding Sunao Manabe (January 31, 2025)
- Bristol-Myers Squibb Appoints Cari Gallman as Executive Vice President and General Counsel, Succeeding Sandra Leung (February 21, 2025)
- Crinetics Pharmaceuticals Appoints Tobin “Toby” Schilke as Chief Financial Officer (February 26, 2025)
- Nurix Therapeutics appoints John Northcott as Chief Commercial Officer (January 22, 2025)
- Arcus Biosciences Appoints Richard Markus, M.D., Ph.D., as Chief Medical Officer (January 21, 2025)
Who to call at Santhera Pharmaceuticals, and when
A new leader at Santhera Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Santhera Pharmaceuticals raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Santhera Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Santhera Pharmaceuticals. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Santhera Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Santhera Pharmaceuticals changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.